Article
A promoter mutation in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causes X-linked sideroblastic anemia.
Blood - 15 Jul 2003
Bekri Soumeya, May Alison, Cotter Philip D, Al-Sabah Ala I, Guo Xiaojun, Masters Gillian S, Bishop David F
Abstract excerpt
X-linked sideroblastic anemia (XLSA) is caused by mutations in the erythroid-specific 5-aminolevulinate synthase gene (ALAS2). XLSA was diagnosed in a 32-year-old woman with a mild phenotype and moderately late onset. Pyridoxine therapy had no effect in the proband, but in her affected son engendered a modest increase in hemoglobin concentration and a 4-fold reduction in ferritin iron. Molecular analysis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
